BEONE MEDICINES LTD. Net Cash Provided by (Used in) Financing Activities, Continuing Operations
BEONE MEDICINES LTD. (ONC) reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $2.53 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2017-05-10
- BEONE MEDICINES LTD. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2017-03-31 was $2.53M, a 98.51% decline year-over-year.
- BEONE MEDICINES LTD. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-12-31 was $198.69M.
- BEONE MEDICINES LTD. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-09-30 was $7.64M, a 19.92% increase year-over-year.
- BEONE MEDICINES LTD. net cash provided by (used in) financing activities, continuing operations for the quarter ending 2016-06-30 was $4.52M.
- BEONE MEDICINES LTD. net cash provided by (used in) financing activities, continuing operations for fiscal 2016 was $380.90M, a 269.07% increase from fiscal 2015.
- BEONE MEDICINES LTD. net cash provided by (used in) financing activities, continuing operations for fiscal 2015 was $103.20M, a 97.84% increase from fiscal 2014.
- BEONE MEDICINES LTD. net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $52.16M.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | $2.53M 10-Q · filed 2017-05-10 | $201.22M derived: sum of 2 quarters · filed 2017-05-10 | $208.87M derived: sum of 3 quarters · filed 2017-05-10 | $213.39M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-12-31 | $198.69M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $206.33M derived: sum of 2 quarters · filed 2017-03-22 | $210.85M derived: sum of 3 quarters · filed 2017-03-22 | $380.90M 10-K · filed 2017-03-22 |
| 2016-09-30 | $7.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $12.16M derived: sum of 2 quarters · filed 2016-11-10 | $182.21M 10-Q · filed 2016-11-10 | $182.09M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-06-30 | $4.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $174.57M 10-Q · filed 2016-08-10 | $174.45M derived: sum of 3 quarters · filed 2017-05-10 | $180.82M derived: sum of 4 quarters · filed 2017-05-10 |
| 2016-03-31 | $170.05M 10-Q · filed 2017-05-10 | $169.93M derived: sum of 2 quarters · filed 2017-05-10 | $176.30M derived: sum of 3 quarters · filed 2017-05-10 | |
| 2015-12-31 | -$119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $6.25M derived: sum of 2 quarters · filed 2017-03-22 | $103.20M 10-K · filed 2017-03-22 | |
| 2015-09-30 | $6.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $103.32M 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $96.95M 10-Q · filed 2016-08-10 | |||
| 2014-12-31 | $52.16M 10-K · filed 2017-03-22 |